Begin main content

CONSULTATION: Proposed Revisions to the pCODR Clinician Engagement Process

Published on: March 20, 2018
Result type: News

Deadline to Submit Feedback:

April 20, 2018 at 5:00 p.m. ET by email to

CADTH invites stakeholder feedback on proposed revisions to the clinician engagement process for its pan-Canadian Oncology Drug Review (pCODR) program. Below is a link to the consultation document.

In February 2016, CADTH launched a pilot project to expand clinician participation in the pCODR process, with the goal of gaining insight into local issues and identifying areas of unmet need. As of December 31, 2017, 169 oncologists have registered to participate and 36 of 41 reviews (88%) have included clinician input. During this pilot phase, CADTH has received input from registered clinicians through a survey, the pCODR Expert Review Committee, and the Provincial Advisory Group on ways to enhance the process.

With the goal of enhancing clinician engagement opportunities, CADTH is proposing the following key changes to the current process:

  • A new template for clinician input, including customized questions that are more specific to the drug and indication that is under review by the pCODR program.
  • Expanding the eligibility criteria beyond oncologists to include oncology pharmacists and oncology nurses who are part of a multi-disciplinary team caring for cancer patients and who meet the proposed criteria.

It is important to note that the pCODR program’s submission and review timelines, notification of pending drug reviews, and process requirements to provide feedback will not change.

CADTH continues to foster relationships with the clinician community and believes that increasing the opportunity for input into the pCODR process will enhance the quality of our reviews and contribute to broader discussions about drug funding decisions in Canada.

Next Steps

Following the consultation period, CADTH will carefully assess all stakeholder feedback. Any decisions about changes to the current pCODR clinician engagement process will be announced in a pCODR Update.

How to Submit Your Feedback

To provide feedback, you must identify yourself — feedback provided by individuals who do not identify themselves and the organization they represent will not be considered.

Only one response per organization will be considered. If more than one response is received, only the first response received will be considered.

Feedback must be provided in 11-point font using this feedback template and saved as a Microsoft Word document (.doc or .docx). Please submit your feedback by April 20, 2018 at 5:00 p.m. ET via email to

Feedback should be presented clearly and succinctly.

If you have questions about our proposed changes, please contact us at .